pregnant women, and women up to four weeks postpartum and their partner women who have just given birth, and their partner children aged six months to younger than five children 19 or younger with chronic medical conditions for which they receive regular medical attention, including morbid obesity people living on First Nations communities health-care workers in district health authorities, long-term care facilities and home-care agencies who provide direct care to patients. This includes family physicians, family practice nurses, pharmacists and pharmacy technicians. people younger than 65 with chronic medical conditions people living with, or providing care in the home for, infants less than six months of age, people living with those at high-risk who cannot be immunized (for example, those with anaphylaxis or severe egg allergies), and those who are immunocompromised and may not respond to vaccine people who work in residential-care facilities, community-based option and small-option homes, group homes and developmental residences. Dr. Robert Strang, chief public health officer, announced how Nova Scotia will implement new guidelines from the Public Health Agency of Canada about second doses of H1N1 vaccine for children today, Nov. 16. Dr. Strang also announced additional groups for whom unadjuvanted vaccine will be used. Healthy children age three to nine will need only one dose of vaccine. The following children will require a second dose a minimum of 21 days after the first dose: Children age three to nine, with a chronic medical condition but who are not immunocompromised, will need a second dose of vaccine. However it is safe for them to receive it after other at-risk groups. “Although some children age three to nine will require two doses 21 days apart, there is no harm for those who are not immunocompromised to wait longer than 21 days,” said Dr. Strang. “Given that we are experiencing a national vaccine shortage we want to ensure those who are most at risk, receive the vaccine first.” The province will announce when they will be eligible for their second dose in the coming weeks. The province has also received federal licensing to provide the 23,500 doses of its unadjuvanted vaccine. The unadjuvanted vaccine is available for pregnant women. It can now be used for those with chronic conditions between the ages of 10 and 64 years who are not immunocompromised. “The unadjuvanted vaccine will be available in physician’s offices for pregnant women and those between 10 and 64 who are not immunocompromised,” said Dr. Strang. “This is good news because it means we now have more vaccine for the at-risk groups.” The province will also offer vaccine to additional groups, based on risk, as soon as supply allows. People in the following groups are still eligible to be immunized: all children between six months and less than three years of age children age three to nine years who are immunocompromised.
Read more on H1N1 Update Second Dose for Kids and Unadjuvanted Vaccine